Bard-Chapeau EA, Li SW, Ding J, Zhang SS, Zhu HH, Princen F, Fang DD, Han T, Bailly-Maitre B, Poli V (2011) Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. Cancer Cell 19(5):629–639
CAS
Article
PubMed
PubMed Central
Google Scholar
Barry V, Winquist A, Steenland K (2013) Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ Health Perspect 121(11–12):1313–1318
PubMed
PubMed Central
Google Scholar
Benninghoff AD, Bisson WH, Koch DC, Ehresman DJ, Kolluri SK, William DE (2011) Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro. Toxicol Sci 120(1):42–58
CAS
Article
PubMed
Google Scholar
Butterworth S, Overduin M, Barr AJ (2014) Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention. Future Med Chem 6(12):1423–1437
CAS
Article
PubMed
Google Scholar
Chang ET, Adami HO, Boffetta P, Cole P, Starr TB, Mandel JS (2014) A critical review of perfluorooctanoate and perfluorooctane sulfonate exposure and cancer risk in humans. Crit Rev Toxicol 44(1):1–81
CAS
Article
PubMed
Google Scholar
Chen LW, Sung SS, Yip MLR, Lawrence HR, Ren Y, Guida WC, Sebti SM, Lawrence NJ, Wu J (2006) Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor. Mol Pharmacol 70(2):562–570
CAS
Article
PubMed
Google Scholar
Conder JM, Hoke RA, de Wolf W, Russell MH, Buck RC (2008) Are PFCAs bioaccumulative? A critical review and comparison with regulatory lipophilic compounds. Environ Sci Technol 42(4):995–1003
CAS
Article
PubMed
Google Scholar
Deakin NO, Turner CE (2008) Paxillin comes of age. J Cell Sci 121(15):2435–2444
CAS
Article
PubMed
PubMed Central
Google Scholar
Deb TB, Wong L, Salomon DS, Zhou GC, Dixon JE, Gutkind JS, Thompson SA, Johnson GR (1998) A common requirement for the catalytic activity and both SH2 domains of SHP-2 in mitogen-activated protein (MAP) kinase activation by the ErbB family of receptors—a specific role for SHP-2 in MAP, but not c-jun amino-terminal kinase activation. J Biol Chem 273(27):16643–16646
CAS
Article
PubMed
Google Scholar
DeWitt J, Shnyra A, Badr M, Loveless S, Hoban D, Frame S, Cunard R, Anderson S, Meade BJ, Peden-Adams M (2009) Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol 39(1):76–94
CAS
Article
PubMed
Google Scholar
Eriksen KT, Sorensen M, McLaughlin JK, Lipworth L, Tjonneland A, Overvad K, Raaschou-Nielsen O (2009) Perfluorooctanoate and perfluorooctane sulfonate plasma levels and risk of cancer in thegeneral Danish population. J Natl Cancer Inst 101(8):605–609
CAS
Article
PubMed
Google Scholar
Florentin A, Deblonde T, Diguio N, Hautemaniere A, Hartemann P (2011) Impacts of two perfluorinated compounds (PFOS and PFOA) on human hepatoma cells: cytotoxicity but no genotoxicity? Int J Hyg Environ Health 214(6):493–499
CAS
Article
PubMed
Google Scholar
Giesy JP, Kannan K (2002) Perfluorochemical surfactants in the environment. Environ Sci Technol 36(7):146A–152A
CAS
Article
PubMed
Google Scholar
Griffith FD, Long JE (1980) Animal toxicity studies with ammonium perfluorooctanoate. Am Ind Hyg Assoc J 41(8):576–583
CAS
Article
PubMed
Google Scholar
Hamann TW, Gstrein F, Brunschwig BS, Lewis NS (2005) Measurement of the free-energy dependence of interfacial charge-transfer rate constants using ZnO/H2O semiconductor/liquid contacts. J Am Chem Soc 127(21):7815–7824
CAS
Article
PubMed
Google Scholar
Hof P, Pluskey S, Dhe-paganon S, Eck MJ, Shoelson SE (1998) Crystal structure of the tyrosine phosphatase SHP-2. Cell 92(4):441–450
CAS
Article
PubMed
Google Scholar
Humblet O, Diaz-Ramirez LG, Balmes JR, Pinney SM, Hiatt RA (2014) Perfluoroalkyl chemicals and asthma among children 12–19 years of age: NHANES (1999–2008). Environ Health Perspect 122(10):1129–1133
CAS
PubMed
PubMed Central
Google Scholar
Jiang CY, Hu FK, Tai YH, Du JL, Mao BB, Yuan ZQ, Wang Y, Wei LX (2012) The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma. J Cancer Res Clin Oncol 138(4):637–646
CAS
Article
PubMed
Google Scholar
Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM (2011) Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999–2008. Environ Sci Technol 45(19):8037–8045
CAS
Article
PubMed
Google Scholar
Kristensen SL, Ramlau-Hansen CH, Ernst E, Olsen SF, Bonde JP, Vested A, Halldorsson TI, Becher G, Haug LS, Toft G (2013) Long-term effects of prenatal exposure to perfluoroalkyl substances on female reproduction. Hum Reprod 28(12):3337–3348
CAS
Article
PubMed
Google Scholar
Kudo N, Suzuki-Nakajima E, Mitsumoto A, Kawashima Y (2006) Responses of the liver to perfluorinated fatty acids with different carbon chain length in male and female mice: in relation to induction of hepatomegaly, peroxisomal beta-oxidation and microsomal 1-acylglycerophosphocholine acyltransferase. Biol Pharm Bull 29(9):1952–1957
CAS
Article
PubMed
Google Scholar
Li S, Hsu DDF, Wang H, Feng GS (2012) Dual faces of SH2-containing protein-tyrosine phosphatase Shp2/PTPN11 in tumorigenesis. Front Med 6(3):275–279
Article
PubMed
Google Scholar
Liu DP, Kong GP, Chen QC, Wang GH, Li J, Xu Y, Lin T, Tian YP, Zhang XK, Yao XS (2011) Fatty acids as natural specific inhibitors of the proto-oncogenic protein Shp2. Bioorg Med Chem Lett 21(22):6833–6837
CAS
Article
PubMed
Google Scholar
Mohi MG, Neel BG (2007) The role of SHP-2 (PTPN11) in cancer. Curr Opin Genet Dev 17(1):23–30
CAS
Article
PubMed
Google Scholar
Muller PJ, Rigbolt KTG, Paterok D, Sobota RM (2013) Protein tyrosine phosphatase SHP-2/PTPN11 mistargeting as a consequence of SH2-domain point mutations associated with Noonan syndrome and leukemia. J Proteom 84:132–147
Article
Google Scholar
Ng CA, Hungerbuhler K (2014) Bioaccumulation of perfluorinated alkyl acids: observations and models. Environ Sci Technol 48(9):4637–4648
CAS
Article
PubMed
Google Scholar
Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, Zobel LR (2007) Half-life of serum elimination of perfluorooctane sulfonate, perfluorohexane sulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115(9):1298–1305
CAS
Article
PubMed
PubMed Central
Google Scholar
Perez F, Nadal M, Navarro-Ortega A, Fabrega F, Domingo JL, Barcelo D, Farre M (2013) Accumulation of perfluoroalkyl substances in human tissues. Environ Int 59:354–362
CAS
Article
PubMed
Google Scholar
Qu N, Wan B, Guo LH (2008) Label-free electrochemical differentiation of phosphorylated and non-phosphorylated peptide by electro-catalyzed tyrosine oxidation. Analyst 133(9):1246–1249
CAS
Article
PubMed
Google Scholar
Ren XM, Zhang YF, Guo LH, Qin ZF, Lv QY, Zhang LY (2015) Structure-activity relations in binding of perfluoroalkyl compounds to human thyroid hormone T3 receptor. Arch Toxicol 89(2):233–242
CAS
Article
PubMed
Google Scholar
Sato I, Kawamoto K, Nishikawa Y, Tsuda S, Yoshida M, Yaegashi K, Saito N, Liu W, Jin YH (2009) Neurotoxicity of perfluorooctane sulfonate (PFOS) in rats and mice after single oral exposure. J Toxicol Sci 34(5):569–574
CAS
Article
PubMed
Google Scholar
Simpson C, Winquist A, Lally C, Steenland K (2013) Relation between perfluorooctanoic acid exposure and strokes in a large cohort living near a chemical plant. Environ Res 127:22–28
CAS
Article
PubMed
Google Scholar
Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29(4):465–468
CAS
Article
PubMed
Google Scholar
Tartaglia M, Niemeyer CM, Shannon KM, Loh ML (2004) SHP-2 and myeloid malignancies. Curr Opin Hematol 11(1):44–50
CAS
Article
PubMed
Google Scholar
Toft G, Jonsson BAG, Lindh CH, Giwercman A, Spano M, Heederik D, Lenters V, Vermeulen R, Rylander L, Pedersen HS (2012) Exposure to perfluorinated compounds and human semen quality in arctic and European populations. Hum Reprod 27(8):2532–2540
CAS
Article
PubMed
Google Scholar
VandenHeuvel JP, Thompson JT, Frame SR, Gillies PJ (2006) Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci 92(2):476–489
CAS
Article
Google Scholar
Vieira VM, Hoffman K, Shin HM, Weinberg JM, Webster TF, Fletcher T (2013) Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis. Environ Health Perspect 121(3):318–323
Article
PubMed
PubMed Central
Google Scholar
Wang SF, Lv QY, Yang Y, Guo LH, Wan B, Zhao LX (2014a) Cellular target recognition of perfluoroalkyl acids: in vitro evaluation of inhibitory effects on lysine decarboxylase. Sci Total Environ 496:381–388
CAS
Article
PubMed
Google Scholar
Wang Y, Rogan WJ, Chen PC, Lien GW, Chen HY, Tseng YC, Longnecker MP, Wang SL (2014b) Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan maternal and infant cohort study. Environ Health Perspect 122(5):529–534
CAS
PubMed
PubMed Central
Google Scholar
Wang F, Liu W, Jin YH, Wang FQ, Ma JS (2015) Prenatal and neonatal exposure to perfluorooctane sulfonic acid results in aberrant changes in miRNA expression profile and levels in developing rat livers. Environ Toxicol 30(6):712–723
CAS
Article
PubMed
Google Scholar
White SS, Fentona SE, Hines EP (2011a) Endocrine disrupting properties of perfluorooctanoic acid. J Steroid Biochem Mol Biol 127(1–2):16–26
CAS
Article
PubMed
PubMed Central
Google Scholar
White SS, Stanko JP, Kato K, Calafat AM, Hines EP, Fenton SE (2011b) Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice. Environ Health Perspect 119(8):1070–1076
CAS
Article
PubMed
PubMed Central
Google Scholar
Wolf CJ, Schmid JE, Lau C, Abbott BD (2012) Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARα) by perfluoroalkyl acids (PFAAs): further investigation of C4–C12 compounds. Reprod Toxicol 33(4):546–551
CAS
Article
PubMed
Google Scholar
Yang Q, Xie Y, Alexson SHE, Nelson BD, DePierre JW (2002) Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. Biochem Pharmacol 63(10):1893–1900
CAS
Article
PubMed
Google Scholar
Yang Y, Guo LH, Qu N, Wei MY, Zhao LX, Wan B (2011) Label-free electrochemical measurement of protein tyrosine kinase activity and inhibition based on electro-catalyzed tyrosine signaling. Biosens Bioelectron 28(1):284–290
CAS
Article
PubMed
Google Scholar
Yu B, Liu W, Yu WM, Loh ML, Alter S, Guvench O, MacKerell AD, Tang LD, Qu CK (2013) Targeting protein tyrosine phosphatase SHP2 for the treatment of PTPN11-associated malignancies. Mol Cancer Ther 12(9):1738–1748
CAS
Article
PubMed
PubMed Central
Google Scholar
Zhang H, Shi Z, Liu Y, Wei Y, Dai J (2008) Lipid homeostasis and oxidative stress in the liver of male rats exposed to perfluorododecanoic acid. Toxicol Appl Pharm 227(1):16–25
CAS
Article
Google Scholar
Zhang LY, Ren XM, Guo LH (2013a) Structure-based investigation on the interaction of perfluorinated compounds with human liver fatty acid binding protein. Environ Sci Technol 47(19):11293–11301
CAS
Article
PubMed
Google Scholar
Zhang T, Guo WJ, Yang Y, Liu W, Guo LL, Gu YH, Shu YQ, Wang L, Wu XF, Hua ZC (2013b) Loss of SHP-2 activity in CD4(+) T cells promotes melanoma progression and metastasis. Sci Rep 3:1–10
Google Scholar
Zhou Z, Shi YL, Vestergren R, Wang T, Liang Y, Cai YQ (2014) Highly elevated serum concentrations of perfluoroalkyl substances in fishery employees from Tangxun Lake, China. Environ Sci Technol 48(7):3864–3874
CAS
Article
PubMed
Google Scholar